HealthBeacon launches global patient safety… – Morningstar

Get 14 Days Free
(Alliance News) – HealthBeacon PLC on Wednesday said it was deploying its “global patient safety technology platform” across the NHS and pharmaceutical industry in Ireland, Australia and New Zealand.
HealthBeacon is a Dublin-based digital therapeutics company developing project for managing injectable medications.
The platform, developed over the last two years in collaboration with the pharmaceutical industry, helps cancer patients take medication “more safely”.
Platform is designed to “replace a paper-based system” to ensure the right people get access to the right drugs. HealthBeacon said it will also “drive down the cost of administration”.
According to HealthBeacon, the platform creates a “new recurring revenue stream”. It anticipates the technology will support more than 1,000 patients by the end of 2022.
To date more than 800 pharmacies have already adopted the system across Ireland and the UK and 12 pharmaceutical companies have bought licenses to replace their paper-based system with HealthBeacon’s streamlined software.
The first drug to be prescribed on the platform is Lenalidomide, used to treat certain cancers.
If Lenalidomide is taken during pregnancy, it poses a risk of birth defects, HealthBeacon said. Using a series of electronic checks and balances, HealthBeacon’s platform ensures the medication cannot be dispensed until a set of agreed safety protocols have been validated.
Co-founder & Chief Technology Officer Kieran Daly: “The Patient Safety Platform is a natural progression for HealthBeacon. Our digital therapeutics systems are designed to boost health outcomes for patients. Our Smart Sharps Bin has been designed to ensure patients take their injectable medication in the most effective way. Now we are using our expertise to design a new software platform ensuring the best outcomes for cancer patients from their medication.”
Shares in HealthBeacon closed up 0.9% at 2.30 pence on Wednesday in London.
By Chris Dorrell; chrisdorrell@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
(Alliance News) – Jet2 PLC on Thursday reported a jump in half-year revenue and a swing to prof…
(Alliance News) – Molten Ventures PLC said on Thursday it syndicated a portion of its Fund of …
(Alliance News) – International Public Partnerships Ltd on Thursday said its portfolio of over …
(Alliance News) – Great Portland Estates PLC on Thursday said that fashion retailer Reserved ha…
(Alliance News) – Safestore Holdings PLC on Thursday said its fourth quarter revenue was up, …
Mining companies are operating in a challenging environment but could now be the time to top up o…
THE WEEK: Morningstar columnist Rodney Hobson provides two pieces of advice to George Osborne, an…
Businesses that have competitive advantages within their industry are good candidates for dividen…
Morningstar reveals the top 10 best performers over the last five years
Morningstar OBSR reveals the top funds for investors seeking exposure to European equities
Two of the world’s most successful investors have some wisdom for you, and it’s not just about wh…
VIDEO: The government thinks changes to EU laws on capital will help pensions, but it’s early day…
Currency markets buoyed by Supreme Court blocking Scotland from holding a referendum without West…
In this series, we ask leading fund managers about everything from their investment strategy, to …
But a V-shaped recovery like the one seen in 2021 is very unlikely in 2023
Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.
About Us
Connect With Us
Get Help
Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings
The Morningstar Star Rating for Stocks is assigned based on an analyst’s estimate of a stocks fair value. It is projection/opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of a stock’s fair value. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. This process culminates in a single-point star rating that is updated daily. A 5-star represents a belief that the stock is a good value at its current price; a 1-star stock isn’t. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Morningstar Star Rating for Stocks, please visit here
Quantitative Fair Value Estimate represents Morningstar’s estimate of the per share dollar amount that a company’s equity is worth today. The Quantitative Fair Value Estimate is based on a statistical model derived from the Fair Value Estimate Morningstar’s equity analysts assign to companies which includes a financial forecast of the company. The Quantitative Fair Value Estimate is calculated daily. It is a projection/opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Quantiative Fair Value Estimate, please visit here

source

Leave a Comment

Your email address will not be published. Required fields are marked *

Lakers sign Thomas Bryant Tom Brady hint at unretirement this year Kevin Durant trade Warriors stars Brooklyn Nets to sign T.J. Warren ‘Minions’ Fire With $110.5 Million debut